Assisting the World Through Advanced Robotic Technology
Founded in Shimizu, Japan in 1976, Intelligent Actuator Incorporated (IAI) has over forty years of experience in the design and manufacture of customized medical...
Medical Device Industry and The Role of the FDA in the United States of America During the Covid-19 Pandemic
By: Dr. Archana Nagarajan
Freelance Scientist at KolabtreeThe COVID-19 pandemic has brought the world to a standstill and hit most countries very hard. The USA...
Journey Towards Accurate and Fast Non-Invasive Mapping of Heart Bio Signals
Three years ago, in Japan, the TDK room temperature, magnetocardiography (MCG) real-time imaging platform was deployed for investigational use only in a multi-year trial. The key goal has been to provide non-invasive mapping of heart bio signals.
Vascular Surgeon in Ireland Views: The COVID-19 Cytokine Storm & the Novel Truth
Based on observations in the USA, Spain, Italy, France, and the UK, and from postmortem of lung involvement in COVID 19, all revealed pulmonary thrombosis, which is not typical ARDS. More alarming, was that patient hypoxemia was not responding to PEEP but high oxygen flow.
From Spain: GPAINNOVA’s RESPIRA Emergency Ventilation Device Receives Approval from the Agencia Española de Medicamentos y Productos Sanitarios to Carry Out a Clinical Trial
GPAINNOVA is leading the way in what they define as the RESPIRA project, focusing all their equipment and resources on the design of their medical ventilator in record time. The company reports that Siemens Digital Industries is its main partner and also has the support of SMC, TEG, and MAM. GPAINNOVA is leading the RESPIRA project, focusing all its equipment and resources on the design of this medical ventilator in record time. It has Siemens Digital Industries as the main partner and also the support of SMC, TEG, and MAM to carry it out.